
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Othera is a pharmaceutical company developing novel therapeutics for age-related diseases of the eye. Otheras lead compound, OT-551 is an eye drop in a Phase II clinical trial for the dry form of macular degeneration (AMD), and recently announced positive interim data from that trial, with full trial results due in mid-2010. The company is also developing novel treatments for glaucoma and neurodegenerative diseases
Specialty pharmaceuticals,dry amd,and ophthalmology
Othera pharmaceuticals operates in the Pharmaceutical manufacturing industry.
Othera pharmaceuticals's revenue is 11m - 100m
Othera pharmaceuticals has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.